No Detail Found!

Division of Canine Mast Cell Tumors According to Tryptase and Chymase Expression using Immunohistochemistry

Author(s)
Malgorzata Kandefer-Gola Department of Pathology, Wroclaw University of Environmental and Life Sciences,C.K. Norwida Street Wroclaw,Poland
Stanislaw Dzimira Department of Pathology, Wroclaw University of Environmental and Life Sciences,C.K. Norwida Street Wroclaw,Poland
Izabela Janus Department of Pathology, Wroclaw University of Environmental and Life Sciences,C.K. Norwida Street Wroclaw,Poland
Rafal Ciaputa Department of Pathology, Wroclaw University of Environmental and Life Sciences,C.K. Norwida Street 31, 50-375 Wroclaw,Poland
Janusz Antoni Madej Department of Pathology, Wroclaw University of Environmental and Life Sciences,C.K. Norwida Street 31, 50-375 Wroclaw,Poland
Przemyslaw Prządka Department and Clinic of Surgery, Wroclaw University of Environmental and Life Sciences,Pl. Grunwaldzki 51, 50-366 Wroclaw,Poland
Abstract
The study aimed at morphological and immunohistochemical analysis of 53 mast cell tumors in dogs. Immunohistochemical studies included determination of cell markers for CD2, CD25, mast cell tryptase and mast cell chymase in canine MCTs and comparison of their expression levels with parameters of malignancy (grade, mitotic index, Ki-67 labelling index and CD117 staining pattern). Patnaik grading system identified 20 dogs with grade I MCTs, 17 with grade II and 16 with grade III. According to Kiupel grading, 34 dogs had low-grade MCT and 19 high-grade tumors. Mitotic index was between 0 and 2.4 (mean 0.4). The CD2 expression was high in 32 of 53 cases, CD25 in 20, tryptase in 44, and chymase in 15. The Ki-67 labelling index ranged between 0 and 55% (mean 11%). Majority of MCTs revealed the second staining pattern of CD117 (n=21). We found that expression of CD2 is linked with tumor malignancy, while CD25 determined tumor development. The tumor division into MCTT and MCTTC may be used as prognostic factor. MCT tryptase positive and chymase positive are less malignant than tryptase positive and chymase negative ones.
Publication Details
Page(s) 446-450
Published Journal: Pakistan Veterinary Journal, Volume: 41, Issue: 3, Year: 2021

Request the full text from PASTIC

Keywords
CD2 CD25 Dog Mast cell chymase Mast cell tryptase Mast cell tumor Mast cell type
0

Citations

0

Downloads

32

Views